Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyban vs Psychodynamic Model Training for Smoking Cessation
NCT00484692Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupropion in tobacco dependence (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: 12-month continuous abstinence. Started Jul 2005; status: completed.
02
Drugs
bupropion
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00484692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484692.